Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02764541
Title	Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Recruitment	Active, not recruiting
Gender	female
Phase	Phase II
Variant Requirements	No
Sponsors	Dana-Farber Cancer Institute
Indications	Her2-receptor negative breast cancer
Therapies	Palbociclib Palbociclib + Tamoxifen Letrozole Tamoxifen
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 11 of 11 entries

Facility	City	State	Zip	Country	Details
Beth Israel Deaconess Medical Center	Boston	Massachusetts	02215	United States	Details
Dana-Farber at St. Elizabeth's Medical Center	Boston	Massachusetts	02135	United States	Details
Dana-Farber Cancer Institute	Boston	Massachusetts	02215	United States	Details
DF/BWCC at Milford Regional Medical Center	Milford	Massachusetts	01757	United States	Details
DF/BWCC in clinical affiliation with South Shore Hospital	South Weymouth	Massachusetts	02190	United States	Details
Eastern Maine Medical Center	Brewer	Maine	04412	United States	Details
Lifespan	Providence	Rhode Island	02903	United States	Details
MD Anderson Cancer Center	Houston	Texas	77030	United States	Details
Sarah Cannon Research Institute	Nashville	Tennessee	37203	United States	Details
Stamford Hospital	Stamford	Connecticut	06904	United States	Details
Vanderbilt University Medical Center	Nashville	Tennessee	37232	United States	Details

Showing 1 to 11 of 11 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field